| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
Tumor markers for hepatocellular carcinoma.
|
2013
|
1.35
|
|
2
|
Target therapy in NSCLC patients: Relevant clinical agents and tumour molecular characterisation.
|
2013
|
1.13
|
|
3
|
The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer.
|
2013
|
1.07
|
|
4
|
Glioma and glioblastoma - how much do we (not) know?
|
2013
|
1.07
|
|
5
|
Outcome of papillary thyroid microcarcinoma: Study of 1,990 cases.
|
2015
|
1.05
|
|
6
|
Epigenetic control of epithelial-mesenchymal-transition in human cancer.
|
2012
|
1.03
|
|
7
|
Carboplatin plus paclitaxel in combination with bevacizumab for the treatment of adenocarcinoma with interstitial lung diseases.
|
2013
|
1.03
|
|
8
|
Extradigital glomus tumor: A case report.
|
2013
|
1.03
|
|
9
|
Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.
|
2014
|
1.02
|
|
10
|
Primary squamous cell carcinoma of the esophagus initially presenting as a large retroperitoneal mass: A case diagnosed as cancer of unknown primary site.
|
2013
|
1.01
|
|
11
|
FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis.
|
2013
|
1.00
|
|
12
|
Prognostic significance of NPM1 mutations in acute myeloid leukemia: A meta-analysis.
|
2013
|
1.00
|
|
13
|
Deguelin, a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemoprevention.
|
2012
|
0.96
|
|
14
|
Oral mucositis in cancer treatment: Natural history, prevention and treatment.
|
2014
|
0.96
|
|
15
|
Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers.
|
2013
|
0.95
|
|
16
|
The proliferation marker thymidine kinase 1 in clinical use.
|
2012
|
0.94
|
|
17
|
Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancer.
|
2014
|
0.93
|
|
18
|
Pigmented keratocystic odontogenic tumor: A case report with review of the literature.
|
2013
|
0.92
|
|
19
|
Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma.
|
2013
|
0.92
|
|
20
|
Clinical characteristics and prognostic analysis of triple-negative breast cancer patients.
|
2013
|
0.92
|
|
21
|
The biology of uterine sarcomas: A review and update.
|
2013
|
0.92
|
|
22
|
Pineal parenchymal tumor of intermediate differentiation: Treatment outcomes of five cases.
|
2013
|
0.91
|
|
23
|
Osteosarcoma with metastasis at initial diagnosis: Current outcomes and prognostic factors in the context of a comprehensive cancer center.
|
2014
|
0.91
|
|
24
|
Prognostic value of peripheral and local forkhead box P3(+) regulatory T cells in patients with non-small-cell lung cancer.
|
2014
|
0.91
|
|
25
|
Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer.
|
2014
|
0.91
|
|
26
|
Precursor T-cell lymphoblastic lymphoma extensively involving the mediastinum, pleura and pericardium: A case report.
|
2014
|
0.90
|
|
27
|
Current status of molecular-targeted drugs for endometrial cancer (Review).
|
2013
|
0.90
|
|
28
|
Expression of miR-486 is a potential prognostic factor after nephrectomy in advanced renal cell carcinoma.
|
2012
|
0.89
|
|
29
|
A new strategy of promoting cisplatin chemotherapeutic efficiency by targeting endoplasmic reticulum stress.
|
2013
|
0.89
|
|
30
|
Extrapancreatic solid pseudopapillary tumors: A clinicopathological analysis of two cases.
|
2016
|
0.89
|
|
31
|
Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma.
|
2013
|
0.89
|
|
32
|
Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer.
|
2014
|
0.89
|
|
33
|
Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth.
|
2013
|
0.88
|
|
34
|
Investigation of neurotrophic tyrosine kinase receptor 1 fusions and neurotrophic tyrosine kinase receptor family expression in non-small-cell lung cancer and sensitivity to AZD7451 in vitro.
|
2014
|
0.88
|
|
35
|
Prognostic value of serum α-fetoprotein in ovarian yolk sac tumors: A systematic review and meta-analysis.
|
2014
|
0.88
|
|
36
|
Advances in intravesical therapy for the treatment of non-muscle invasive bladder cancer (Review).
|
2014
|
0.88
|
|
37
|
Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis.
|
2014
|
0.87
|
|
38
|
Giant hydronephrosis due to ureteropelvic junction obstruction: A rare case report, and a review of the literature.
|
2016
|
0.87
|
|
39
|
Long non-coding RNAs and hepatocellular carcinoma.
|
2014
|
0.87
|
|
40
|
Association between vascular endothelial growth factor gene polymorphisms and bladder cancer risk.
|
2014
|
0.87
|
|
41
|
Expression and clinical significance of girdin in gastric cancer.
|
2014
|
0.87
|
|
42
|
Analysis of clinical characteristics, diagnosis, treatment and prognosis of 46 patients with primary gastrointestinal non-Hodgkin lymphoma.
|
2013
|
0.87
|
|
43
|
Extracranial metastasis of gliobastoma: Three illustrative cases and current review of the molecular pathology and management strategies.
|
2015
|
0.87
|
|
44
|
Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors.
|
2014
|
0.87
|
|
45
|
Impact of aberrant methylation of microRNA-9 family members on non-small cell lung cancers.
|
2012
|
0.87
|
|
46
|
The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer.
|
2015
|
0.86
|
|
47
|
Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review).
|
2013
|
0.86
|
|
48
|
microRNA expression is able to predict response to chemoradiotherapy in rectal cancer.
|
2012
|
0.86
|
|
49
|
Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup Surveillance.
|
2013
|
0.86
|
|
50
|
Maxillary pain is the first indication of the presence of multiple myeloma: A case report.
|
2013
|
0.86
|